Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression.
Carole Mendoza, MBA, MPH
Advertisement
Articles by Carole Mendoza, MBA, MPH
Panelists discuss how metabolic dysfunction drives liver injury, highlighting early recognition of the obesity–MASH connection as key to prevention.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch
2
Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC
3
Noninvasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial
4
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
5
